These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sustained release hormonal preparations. 5. Absorption of 6-methyl-17-alpha-acetoxypregna-4,6-diene-3,20-dione from polydimethylsiloxane implants in vivo. Benagiano G; Ermini M; Chang CC; Sundaram K; Kincl FA Acta Endocrinol (Copenh); 1970 Jan; 63(1):29-38. PubMed ID: 5467019 [No Abstract] [Full Text] [Related]
3. Diffusion of progestogens through Silastic rubber implants. Lifchez AS; Scommegna A Fertil Steril; 1970 May; 21(5):426-30. PubMed ID: 4101385 [TBL] [Abstract][Full Text] [Related]
4. [Clinical test with a prolonged-action estrogen-progesterone combination administered intramuscularly]. Mateos Cándano M; Ochoa Bernal MR; Ruiz Moreno JA Ginecol Obstet Mex; 1969 Sep; 26(155):275-82. PubMed ID: 5402846 [No Abstract] [Full Text] [Related]
5. Long-term application of steroids enclosed in dimethyl-polysiloxane (silastic): in vitro and in vivo experiments. Schuhmann R; Taubert HD Acta Biol Med Ger; 1970; 24(6):897-910. PubMed ID: 4098098 [No Abstract] [Full Text] [Related]
6. Sustained release hormonal preparations. 9. Plasma levels and accumulation into various tissues of 6-methyl-17 alpha-acetoxy-4,6-pregnadiene-3,20-dione after oral administration or absorption from polydimethylsiloxane implants. Kincl FA; Angee I; Chang CC; Rudel HW Acta Endocrinol (Copenh); 1970 Jul; 64(3):508-18. PubMed ID: 4916445 [No Abstract] [Full Text] [Related]
8. [Prolonged effect of contraceptive steroids in experiment]. Cekan Z; Kincl FA Cesk Gynekol; 1967 Apr; 32(3):181-3. PubMed ID: 6082986 [No Abstract] [Full Text] [Related]
9. Excretion of [6-14C]megestrol acetate (6 methyl-17 acetoxypregna-4,6 diene, 3,20 dione) released from subcutaneous silastic implants in women. Coutinho EM; Ferreira DA; Prates H; Kincl F J Reprod Fertil; 1970 Nov; 23(2):345-7. PubMed ID: 5481731 [No Abstract] [Full Text] [Related]
10. Sustained release hormonal preparations. 12. Plasma levels of 6-methyl-17-alpha-acetozy-4,6-pregnadiene-3,20-dione in hamsters. Zbuzkova V; Kincl FA Steroids; 1970 Oct; 16(4):447-50. PubMed ID: 5503549 [No Abstract] [Full Text] [Related]
11. [Single monthly injection for contraception]. Artner J; Friedrich F Geburtshilfe Frauenheilkd; 1970 Jun; 30(6):554-64. PubMed ID: 5475938 [No Abstract] [Full Text] [Related]
12. Studies on sustained contraceptive effects with subcutaneous polydimethylsiloxane implants. 1. Diffusion of megestrol acetate in humans. Benagiano G; Ermini M; Carenza L; Rolfini G Acta Endocrinol (Copenh); 1973 Jun; 73(2):335-46. PubMed ID: 4740833 [No Abstract] [Full Text] [Related]
13. Sustained release hormonal preparations. 11. Biological effectiveness of (DL)-13 -ethyl-17 -ethynyl-17 -hydroxy-4-gonen-3-one released from polydimethylsiloxane capsules. Zbuzková V; Kincl FA Endocrinol Exp; 1970; 4(4):215-20. PubMed ID: 5317371 [No Abstract] [Full Text] [Related]
14. Sustained-release hormonal preparations XV: release of progesterone from cholesterol pellets in vivo. Joseph AA; Hill JL; Patel J; Patel S; Kincl FA J Pharm Sci; 1977 Apr; 66(4):490-3. PubMed ID: 856969 [TBL] [Abstract][Full Text] [Related]
15. Acceptability of long-term contraceptive steroid administration in humans by subcutaneous Silastic capsules. Tatum HJ; Coutinho EM; Filho JA; Sant'anna AR Am J Obstet Gynecol; 1969 Dec; 105(7):1139-43. PubMed ID: 5352595 [No Abstract] [Full Text] [Related]
16. Fertility control in women with a progestogen released in microquantities from subcutaneous capsules. Croxatto H; Díaz S; Vera R; Etchart M; Atria P Am J Obstet Gynecol; 1969 Dec; 105(7):1135-8. PubMed ID: 5352594 [No Abstract] [Full Text] [Related]